Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
ophthalmic medication |
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
S01EE05
|
| gptkbp:brand |
gptkb:Vyzulta
|
| gptkbp:CASNumber |
860005-02-1
|
| gptkbp:chemicalFormula |
C27H41NO8
|
| gptkbp:developer |
gptkb:Bausch_+_Lomb
|
| https://www.w3.org/2000/01/rdf-schema#label |
latanoprostene bunod
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
prostaglandin analog
nitric oxide donor |
| gptkbp:routeOfAdministration |
topical (eye drops)
|
| gptkbp:sideEffect |
eye pain
eye irritation conjunctival hyperemia |
| gptkbp:usedFor |
ocular hypertension
open-angle glaucoma |
| gptkbp:bfsParent |
gptkb:Vesneo
|
| gptkbp:bfsLayer |
7
|